SCHEMBL4883799

SCHEMBL4883799

CC(C)(C)[Si](C)(C)OC1=CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PREP P48147 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886317 0.98
SCHEMBL14269373 0.94 PREP (0.31) PREP
SCHEMBL29860057 0.84 PREP (0.33) PREP
SCHEMBL817040 0.79 ALDH1A1 (0.33)
SCHEMBL3456698 0.79
SCHEMBL2386417 0.78 ALDH1A1 (0.32)
SCHEMBL2386422 0.78 ALDH1A1 (0.32)
SCHEMBL28488936 0.78 ALDH1A1 (0.32)
SCHEMBL7258256 0.76
SCHEMBL10978153 0.74 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022138893-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY MUアイオニックソリューションズ株式会社 2022-06-30 WO disclosed
CN-108864172-B Green synthesis method of 1, 2-di (trialkylsiloxy) cyclohexene 上虞新和成生物化工有限公司 2020-09-29 CN disclosed
CN-104011045-B Dihydrobenzoxazine and dihydropyridinooxazine derivatives 诺华股份有限公司 2016-08-24 CN disclosed
US-8809567-B2 Method for producing silylenol ethers KYOTO UNIVERSITY (JP) 2014-08-19 US disclosed
US-8809567-B2 Method for producing silylenol ethers KYOTO UNIVERSITY (JP) 2014-08-19 US disclosed
US-20130053567-A1 METHOD FOR PRODUCING SILYLENOL ETHERS KYOTO UNIVERSITY (JP) 2013-02-28 US disclosed
US-20130053567-A1 METHOD FOR PRODUCING SILYLENOL ETHERS KYOTO UNIVERSITY (JP) 2013-02-28 US disclosed
US-20080051598-A1 Process for Production of Polysubstituted Cyclobutanes and Polysubstituted Cyclobutenes NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) 2008-02-28 US disclosed
US-20080051598-A1 Process for Production of Polysubstituted Cyclobutanes and Polysubstituted Cyclobutenes NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) 2008-02-28 US disclosed
EP-1775300-A1 PROCESS FOR PRODUCTION OF POLYSUBSTITUTED CYCLOBUTANES AND POLYSUBSTITUTED CYCLOBUTENES National University Corporation Tohoku Unversity (JP) 2007-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053567-A1 METHOD FOR PRODUCING SILYLENOL ETHERS AKR7A2, MSMO1, CYP2E1 PREP 3729/4885
US-20080051598-A1 Process for Production of Polysubstituted Cyclobutanes and Polysubstituted Cyclobutenes SBDS, OSTC, FASN PREP 4075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.